Evonik closes the second quarter with strong results. Sales increased 31 percent year-on-year to €4,772 million due to higher selling prices and positive currency effects ... MORE
Evonik, one of the world’s leading providers of personal care ingredients, is continuing its portfolio transformation to System Solutions by divesting its U.S. betaine business. ... MORE
Evonik’s EUDRACAP® enteric easy-to-handle capsules are now globally available produced under IPEC-GMP. ... MORE
Evonik’s recombinant, non-animal-derived collagen platform is now available at commercial scale. ... MORE
Evonik has received two industry awards for its newly launched short-chain ceramide SPHINOX® Lift and vegetal sourced cholesterol-derivative TEGO® Sterol 7-DHC V. ... MORE
The latest TEGO® dispersing agent in the portfolio is readily biodegradable so improves the sustainability of pigment and colored coatings production ... MORE
